India Weighs Red Warning Labels on Cough Syrups to Curb Under-4 Use

India's drug regulator is examining a proposal to place a prominent red warning and pictorial labelling on cough syrup bottles, aimed at discouraging their use in children below the age of four.

The move follows concerns over inappropriate prescribing of these medicines to young children and broader questions around drug safety. Under the plan being considered, the labels would carry pictorials depicting school-age children, reinforcing that the products are not meant for those under four.

The proposed warning is intended to be displayed prominently, with the red colouring designed to draw the attention of parents, caregivers and pharmacists at the point of purchase or dispensing.

Cough syrups are widely sold in India and are commonly given to children for colds and related symptoms. The regulator's deliberations reflect a growing focus on ensuring that such preparations are used only where medically appropriate, and that clear cautionary information reaches consumers.

Details of the labelling requirement, including its final wording and the timeline for implementation, have not been disclosed. The proposal remains under consideration.